(Q50506281)

English

Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.

scientific article published on 12 August 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

1 reference

based on heuristic

inferred from title

Antoni Castells

17

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

author name string

María Dolores Giráldez

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Juan José Lozano

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Míriam Cuatrecasas

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Virginia Alonso-Espinaco

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Joan Maurel

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Maribel Mármol

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Carlos Hörndler

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Javier Ortego

8

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Vicente Alonso

9

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Pilar Escudero

10

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Gina Ramírez

11

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Christoph Petry

12

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Luis Lasalvia

13

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Kerstin Bohmann

14

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Ralph Wirtz

15

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Aurea Mira

16

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

language of work or name

0 references

publication date

12 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

132

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

1090-1097

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Systemic therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Design and endpoints of clinical and translational trials in advanced colorectal cancer. a proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Systematic review of microsatellite instability and colorectal cancer prognosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

S100 proteins in cartilage: role in arthritis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

S100A2 level changes are related to human periodontitis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

The role of S100 genes in breast cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

A review of the S100 proteins in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Gene expression signature for recurrence in stage III colorectal cancers.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

S100A2 in cancerogenesis: a friend or a foe?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Multigene Assays to Improve Assessment of Recurrence Risk and Benefit From Chemotherapy in Early-Stage Colon Cancer: Has the Time Finally Arrived, or Are We Still Stage Locked?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27747

21 January 2018

Identifiers

10.1002/IJC.27747

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/22833293

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50506281&oldid=1534020893"